Modern Rheumatology

Papers
(The H4-Index of Modern Rheumatology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies50
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study33
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar33
Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases31
The dietary acid load is associated with disease severity in psoriatic arthritis31
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation30
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance29
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review27
The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet’s disease: A systematic review and meta-analysis25
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis24
Treatment outcomes of periprosthetic fracture following unlinked total elbow arthroplasty: A case series study23
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis23
The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting23
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease23
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study22
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study22
Correction to: Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs20
Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study19
Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort19
0.14799284934998